Recent Advances in the Development of Selective CB2 Agonists as Promising Anti-Inflammatory Agents

E-ISSN： 1875-533x|19|21|3457-3474

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.21, 2012-07, pp. : 3457-3474

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in the Development of Selective Ligands for the Cannabinoid CB2 Receptor

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 3, 2008-01 ,pp. : 187-204

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Inflammatory Activities of 2-Agonists

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-09 ,pp. : 271-277

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabinoid CB1 and CB2 Receptor Ligand Specificity and the Development of CB2-Selective Agonists

Current Medicinal Chemistry, Vol. 15, Iss. 14, 2008-06 ,pp. : 1428-1443

Bentham Science Publishers

Access to resources Recommend Favorite

Selective cyclooxygenase-2 inhibitors as non-ulcerogenic anti-inflammatory agents

By Kalgutkar A.S.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 7, 1999-07 ,pp. : 831-849

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in Medicinal Chemistry of Sulfonamides. Rational Design as Anti-Tumoral, Anti-Bacterial and Anti-Inflammatory Agents

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 1, 2013-01 ,pp. : 70-86

Bentham Science Publishers

Access to resources Recommend Favorite